|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3576788 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18706965.3 |
| Date of filing the European patent application | 2018-02-02 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-25 |
| (46) | Date of publication of the claims translation | 2025-08-11 |
| (86) | Number | PCT/EP2018/052665 |
| Date | 2018-02-02 |
| (87) | Number | WO 2018/141910 |
| Date | 2018-08-09 |
| (30) | Number | Date | Country code |
| 201762453952 P | 2017-02-02 | US |
| (72) |
MCAULEY, Arnold , US
GHATTYVENKATAKRISHNA, Pavan , US
ABEL, Jeff , US
HUH, Joon , US
POMPE, Cornelius , DE
KANAPURAM, Sekhar , US
TREUHEIT, Michael , US
JAGANNATHAN, Bharadwaj , US
|
| (73) |
Amgen Research (Munich) GmbH ,
Staffelseestrasse 2, 81477 München,
DE
Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 91320-1799, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė kompozicija su žema Ph verte, apimanti antikūnų ir T ląstelių konstruktus |
| LOW PH PHARMACEUTICAL COMPOSITION COMPRISING T CELL ENGAGING ANTIBODY CONSTRUCTS |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 9 | 208.00 EUR |
| 2027-02-02 |